Karen has also served as Senior Vice President of Global Quality. In that position, she was responsible for ensuring the continuing safety and high quality of our worldwide portfolio of products. Some of her key accomplishments included lifting of the consent decree at CSL's Kankakee facility, supporting first-round licensing approvals, delivering an excellent inspectional track record with many global regulatory bodies and the implementation of several global quality systems within CSL.

Karen joined the company in 1994, when CSL Limited purchased JRH Biosciences. At that time, Karen led the development of a new state-of-the-art manufacturing process. Joining CSL in the role of Technical Director, Karen advanced through CSL in roles of increasing responsibility until she joined the executive management team in the quality role in 2006.

Karen holds a doctoral degree in immunology and virology from the University of Maine.

Leading the Way on Rare & Serious Diseases

We are committed to saving and improving the lives of people with rare and serious diseases worldwide.